Drug intelligence / Profile preview

buffered local anesthesia

Development stage
Unknown
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Local Infiltration, Subcutaneous, Intradermal, Nerve Block
01

Overview

Buffered local anesthesia refers to a compounded formulation in which a standard local anesthetic solution—most commonly lidocaine (often with epinephrine), bupivacaine, or articaine—is mixed with sodium bicarbonate immediately prior to administration. The addition of sodium bicarbonate raises the pH of the acidic anesthetic solution closer to physiological levels. This buffering process reduces pain on injection, speeds onset of anesthesia, and may prolong the duration of action compared to unbuffered solutions. Buffered formulations are not commercially available as pre-mixed products due to stability concerns; they are typically prepared at the point of care by clinicians for procedures requiring rapid and comfortable onset of numbness[1][2][3][4][6]. The mechanism involves both reduction in tissue irritation from acidity and increased proportion of non-ionized (active) drug available for nerve penetration.

Other names
buffered local anestheticbuffered lidocainesodium bicarbonate-buffered local anesthetic
02

Targets

SCN3A (Sodium channel protein type 3 subunit alpha)

Beyond the preview

Go deeper on buffered local anesthesia.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on buffered local anesthesia.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call